A Systematic Review of Economic Studies on Biological Agents Used to Treat Crohn’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Systematic Review of Economic Studies on Biological Agents Used to Treat Crohn’s Disease

Published:2013-11 Issue:12 Volume:19 Page:2673-2694
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Tang Derek H.,Harrington Amanda R.,Lee Jeannie K.,Lin Mark,Armstrong Edward P.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference63 articles.

1. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences

2. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978???2002

3. The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States

4. Remission in Patients with Crohn's Disease is Associated with Improvement in Employment and Quality of Life and a Decrease in Hospitalizations and Surgeries

5. Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease;Journal of Crohn's and Colitis;2023-01-10

2. Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review;MDM Policy & Practice;2023-01

3. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia;Journal of Medical Economics;2020-07-23

4. Cost-Effectiveness of Reimbursing Infliximab for Moderate to Severe Crohn’s Disease in China;Advances in Therapy;2019-12-03

5. Cost-effectiveness and Clinical Outcomes of Early Anti–Tumor Necrosis Factor–α Intervention in Pediatric Crohn’s Disease;Inflammatory Bowel Diseases;2019-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3